CMS’ interim rule states that Medicare will cover Covid-19 vaccines approved by the FDA, including those receiving emergency use authorization, in a reversal from its usual policy. The vaccine will be made available at no cost to Medicare beneficiaries.
Medicare to cover all FDA-approved Covid-19 vaccines
No Comments
Previous Post
Covid-19’s digital imperative for biopharma and medtech
Next Post
Adding patient photos to EHR significantly reduces order errors, study find
Recent Posts
- Gilead’s cell therapy Yescarta awarded FDA approval for follicular lymphoma 08/03/2021
- FDA approval brings remote programming for Abbott’s deep brain stimulation device 08/03/2021
- Beckman Coulter seeks authorization for $4 antigen test 28/01/2021
- 3 tech-driven innovative patient engagement strategies transforming healthcare today 09/12/2020
- Lucira Covid-19 test is first to get FDA nod for home use 19/11/2020
Categories
- Coding (3)
- news (17)
- Photography (3)
- Social Marketing (3)
- uncategorized (1)
- WordPress (4)